Gastric Collision Tumors: An Insight into Their Origin and Clinical Significance

Table 4

Gastrointestinal stromal tumor and gastric adenocarcinoma collision tumors.

Author	Sex/age	GIST	GA	Nodes	Follow-up	Adjuvant treatment
Liu et al. [54], 2002	M/70	0/50 hpf	AGC, I	GA (+)	3 m (DOAC)	None
Katsoulis et al. [55], 2007	F/78	N/A	AGC, PD, D	GA (+)	N/A	N/A
Idema et al. [56], 2008	M/71	<5/50 hpf	AGC, D	GA (+)	N/A	N/A
Trabelsi et al. [57], 2008	M/54	0/50 hpf	AGC, SRC	GA (+)	N/A	N/A
Bi et al. [58], 2009	F/73	5/50 hpf	WD, I	GA (+)	N/A	N/A
Kleist et al. [16], 2010	F/86	<5/50 hpf	WD, I	(−)	11 m	N/A
	M/78	<5/50 hpf	PD, SRC	(−)	4 m (DOD)	N/A

GIST: Gastrointestinal stromal tumor.
GA: Gastric adenocarcinoma.
Hpf: High power field.
AGC: Advanced gastric cancer.
D: Diffuse.
I: Intestinal.
SRC: Signet ring cell.
PD: Poorly differentiated.
m: Months.
DOD: Dead of disease.
DOAC: Dead of another cause.
N/A: Not available.